Novartis CEO 'Very Confident' on Sales Target, Doesn't Fear …
Nov 2, 2024 · ZURICH (Reuters) - Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant ...
WSJ News Exclusive | How Novartis’s CEO Learned From His …
Sep 3, 2023 · After some deals and drug launches disappointed, Vas Narasimhan heard from investors—and hired an outspoken Wall Street analyst to manage strategy.
Novartis Lifts Guidance Again After Key Drugs Help Results - MSN
Novartis Chief Executive Vas Narasimhan said in a call with reporters that growth momentum and quarterly guidance lifts were a result of the company’s refocused pipeline portfolio and ...
JPM24: As cancer players jump head-first into ADC field, Novartis …
Jan 8, 2024 · Novartis CEO Vas Narasimhan explained his perspective on the oncology landscape at the J.P. Morgan Healthcare Conference on Monday. (Novartis) San Francisco—Nearly all top cancer drugmakers...
AI helping us make smarter, faster decisions, says Novartis R&D …
Nov 1, 2024 · Vas Narasimhan is global head of drug development and chief medical officer at Novartis, and spoke to pharmaphorum at the company’s recent Q4 results conference. He says numerous pilot...
Novartis unveils new focused strategy, underpinned by eight …
Sep 22, 2022 · “Novartis is transforming into a ‘pure-play’ Innovative Medicines company. Our strategy is focused on five core attractive therapeutic areas, key technology platforms, and the US market, with the aim to increase value per new molecular entity from our deep pipeline”, said Vas Narasimhan, CEO of Novartis.
Vas Narasimhan of Novartis Becomes Chair of PhRMA Board
Feb 8, 2023 · The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Novartis CEO Vas Narasimhan, M.D., has assumed the role of chair of the PhRMA Board of Directors. Daniel O'Day of Gilead Sciences, Inc. and Albert Bourla of Pfizer Inc. also assumed new leadership positions on the PhRMA board.
Vasant (Vas) Narasimhan, M.D. - Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
Vasant Narasimhan | Novartis
Jan 31, 2024 · Since becoming CEO of Novartis in 2018, Vas has led a strategic and cultural transformation to build a fully focused medicines company—one that delivers high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.
Top Novartis executives to depart as company restructures
Apr 4, 2022 · Since becoming Novartis’ CEO in 2018, Vas Narasimhan has made a series of major moves to overhaul the drugmaker, one of the world’s largest. A month after Narasimhan took over, the company sold its stake in a joint consumer …